Keith Wilson
Faculty Member
Last active: 3/17/2021

  1. Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants. Caston RR, Sierra JC, Foegeding NJ, Truelock MD, Campbell AM, Frick-Cheng AE, Bimczok D, Wilson KT, McClain MS, Cover TL (2020) Infect Immun 88(6)
    › Primary publication · 32284370 (PubMed) · PMC7240096 (PubMed Central)
  2. Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection. Whary MT, Avenia JMR, Bravo LE, Lofgren JL, Lertpiriyapong K, Mera-Giler R, Piazuelo MB, Correa P, Peek RM, Wilson KT, Fox JG (2020) Cancer Epidemiol : 101726
    › Primary publication · 32447242 (PubMed) · PMC7755565 (PubMed Central)
  3. Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells. Palrasu M, Zaika E, El-Rifai W, Garcia-Buitrago M, Piazuelo MB, Wilson KT, Peek RM, Zaika AI (2020) J Clin Invest 130(5): 2422-2434
    › Primary publication · 32250340 (PubMed) · PMC7190987 (PubMed Central)
  4. A Summary of the 2020 Gastric Cancer Summit at Stanford University. Huang RJ, Koh H, Hwang JH, Summit Leaders (2020) Gastroenterology 159(4): 1221-1226
    › Primary publication · 32707045 (PubMed) · PMC7577947 (PubMed Central)
  5. An interspecies translation model implicates integrin signaling in infliximab-resistant inflammatory bowel disease. Brubaker DK, Kumar MP, Chiswick EL, Gregg C, Starchenko A, Vega PN, Southard-Smith AN, Simmons AJ, Scoville EA, Coburn LA, Wilson KT, Lau KS, Lauffenburger DA (2020) Sci Signal 13(643)
    › Primary publication · 32753478 (PubMed) · PMC7459361 (PubMed Central)
  6. α-Difluoromethylornithine reduces gastric carcinogenesis by causing mutations in . Sierra JC, Suarez G, Piazuelo MB, Luis PB, Baker DR, Romero-Gallo J, Barry DP, Schneider C, Morgan DR, Peek RM, Gobert AP, Wilson KT (2019) Proc Natl Acad Sci U S A 116(11): 5077-5085
    › Primary publication · 30804204 (PubMed) · PMC6421409 (PubMed Central)
  7. Targeting Gut Microbiome Interactions in Service-Related Gastrointestinal and Liver Diseases of Veterans. Bajaj JS, Sharma A, Dudeja PK, Collaborators (2019) Gastroenterology 157(5): 1180-1183.e1
    › Primary publication · 31404532 (PubMed) · PMC7249241 (PubMed Central)
  8. Serum Polyunsaturated Fatty Acids Correlate with Serum Cytokines and Clinical Disease Activity in Crohn's Disease. Scoville EA, Allaman MM, Adams DW, Motley AK, Peyton SC, Ferguson SL, Horst SN, Williams CS, Beaulieu DB, Schwartz DA, Wilson KT, Coburn LA (2019) Sci Rep 9(1): 2882
    › Primary publication · 30814550 (PubMed) · PMC6393448 (PubMed Central)
  9. Resolution of Gastric Cancer-Promoting Inflammation: A Novel Strategy for Anti-cancer Therapy. Piazuelo MB, Riechelmann RP, Wilson KT, Algood HMS (2019) Curr Top Microbiol Immunol : 319-359
    › Primary publication · 31123895 (PubMed) · PMC6602908 (PubMed Central)
  10. Preventing Gastric Cancer Development by Inhibiting the Virulence of H. pylori Infection. Wilson KT (2019) Oncology (Williston Park) 33(6): 227-31
    › Primary publication · 31219607 (PubMed) · PMC6685684 (PubMed Central)